CcpA is important for growth and virulence of Enterococcus faecium

Infection and Immunity

Volumn 82, Issue 9, 2014, Pages 3580-3587

  Somarajan, Sudha R ^a   Roh, Jung H ^a   Singh, Kavindra V ^a   Weinstock, George M ^b   Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATABOLITE CONTROL PROTEIN A;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; DELETION MUTANT; ENTEROCOCCUS FAECIUM; GENE DELETION; GENE SEQUENCE; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; RAT; STOP CODON; WILD TYPE;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL ADHESION; BACTERIAL PROTEINS; BIOFILMS; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECIUM; MOLECULAR SEQUENCE DATA; RATS; SEQUENCE DELETION; VIRULENCE;

EID: 84906070908     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01911-14     Document Type: Article

References (45)

1. Arias CA, Murray BE. 2012. The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10:266-278. http://dx.doi.org/10.1038/nrmicro2761.
2. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections. Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011. http://dx.doi.org/10.1086/591861. (Erratum, 30:107, 2009, http://dx.doi.org/10.1086/595954.).
3. Murray BE. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:710-721. http://dx.doi.org/10.1056/NEJM200003093421007.
4. Galloway-Pena JR, Nallapareddy SR, Arias CA, Eliopoulos GM, Murray BE. 2009. Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. J. Infect. Dis. 200:1566-1573. http://dx.doi.org/10.1086/644790.
5. Somarajan SR, Murray BE. 2013. Could a phosphotransferase system provide the means to control outbreaks of Enterococcus faecium infection? J. Infect. Dis. 207:1633-1636. http://dx.doi.org/10.1093/infdis/jit080.
6. Lebreton F, van Schaik W, McGuire AM, Godfrey P, Griggs A, Mazumdar V, Corander J, Cheng L, Saif S, Young S, Zeng Q, Wortman J, Birren B, Willems RJ, Earl AM, Gilmore MS. 2013. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. mBio 4(4):e00534-13. http://dx.doi.org/10.1128/mBio.00534-13.
7. Nallapareddy SR, Singh KV, Murray BE. 2006. Construction of improved temperature-sensitive and mobilizable vectors and their use for constructing mutations in the adhesin-encoding acm gene of poorly transformable clinical Enterococcus faecium strains. Appl. Environ. Microbiol. 72:334-345. http://dx.doi.org/10.1128/AEM.72.1.334-345.2006.
8. Willems RJ, Homan W, Top J, van Santen-Verheuvel M, Tribe D, Manzioros X, Gaillard C, Vandenbroucke-Grauls CM, Mascini EM, van Kregten E, van Embden JD, Bonten MJ. 2001. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357:853-855. http://dx.doi.org/10.1016/S0140-6736(00)04205-7.
9. Rice LB, Carias L, Rudin S, Vael C, Goossens H, Konstabel C, Klare I, Nallapareddy SR, Huang W, Murray BE. 2003. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J. Infect. Dis. 187:508-512. http://dx.doi.org/10.1086/367711.
10. Sillanpaa J, Nallapareddy SR, Prakash VP, Qin X, Hook M, Weinstock GM, Murray BE. 2008. Identification and phenotypic characterization of a second collagen adhesin, Scm, and genome-based identification and analysis of 13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus faecium. Microbiology 154:3199-3211. http://dx.doi.org/10.1099/mic.0.2008/017319-0.
11. Sillanpaa J, Prakash VP, Nallapareddy SR, Murray BE. 2009. Distribution of genes encoding MSCRAMMs and pili in clinical and natural populations of Enterococcus faecium. J. Clin. Microbiol. 47:896-901. http://dx.doi.org/10.1128/JCM.02283-08.
12. Zhang X, Top J, de Been M, Bierschenk D, Rogers M, Leendertse M, Bonten MJ, van der Poll T, Willems RJ, van Schaik W. 2013. Identification of a genetic determinant in clinical Enterococcus faecium strains that contributes to intestinal colonization during antibiotic treatment. J. Infect. Dis. 207:1780-1786. http://dx.doi.org/10.1093/infdis/jit076.
13. Leavis HL, Willems RJ, van Wamel WJ, Schuren FH, Caspers MP, Bonten MJ. 2007. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog. 3:e7. http://dx.doi.org/10.1371/journal.ppat.0030007.
14. de Been M, van Schaik W, Cheng L, Corander J, Willems RJ. 2013. Recent recombination events in the core genome are associated with adaptive evolution in Enterococcus faecium. Genome Biol. Evol. 5:1524-1535. http://dx.doi.org/10.1093/gbe/evt111.
15. Nallapareddy SR, Weinstock GM, Murray BE. 2003. Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol. Microbiol. 47:1733-1747. http://dx.doi.org/10.1046/j.1365-2958.2003.03417.x.
16. Nallapareddy SR, Singh KV, Okhuysen PC, Murray BE. 2008. A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect. Immun. 76:4110-4119. http://dx.doi.org/10.1128/IAI.00375-08.
17. Nallapareddy SR, Singh KV, Murray BE. 2008. Contribution of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental endocarditis. Infect. Immun. 76:4120-4128. http://dx.doi.org/10.1128/IAI.00376-08.
18. Kristich CJ, Chandler JR, Dunny GM. 2007. Development of a hostgenotype-independent counterselectable marker and a high-frequency conjugative delivery system and their use in genetic analysis of Enterococcus faecalis. Plasmid 57:131-144. http://dx.doi.org/10.1016/j.plasmid.2006.08.003.
19. Panesso D, Montealegre MC, Rincon S, Mojica MF, Rice LB, Singh KV, Murray BE, Arias CA. 2011. The hylEfm gene in pHylEfm of Enterococcus faecium is not required in pathogenesis of murine peritonitis. BMC Microbiol. 11:20. http://dx.doi.org/10.1186/1471-2180-11-20.
20. Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock GM. 2011. Genetic basis for in vivo daptomycin resistance in enterococci. N. Engl. J. Med. 365:892-900. http://dx.doi.org/10.1056/NEJMoa1011138.
21. Singh KV, Nallapareddy SR, Sillanpaa J, Murray BE. 2010. Importance of the collagen adhesin ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis. PLoS Pathog. 6:e1000716. http://dx.doi.org/10.1371/journal.ppat.1000716.
22. Singh KV, Coque TM, Weinstock GM, Murray BE. 1998. In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol. Med. Microbiol. 21:323-331. http://dx.doi.org/10.1111/j.1574-695X.1998.tb01180.x.
23. Dutka-Malen S, Evers S, Courvalin P. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
24. Mohamed JA, Huang W, Nallapareddy SR, Teng F, Murray BE. 2004. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect. Immun. 72: 3658-3663. http://dx.doi.org/10.1128/IAI.72.6.3658-3663.2004.
25. Almohamad S, Somarajan SR, Singh KV, Nallapareddy SR, Murray BE. 2014. Influence of isolate origin and presence of various genes on biofilm formation by Enterococcus faecium. FEMS Microbiol. Lett. 353:151-156. http://dx.doi.org/10.1111/1574-6968.12418.
26. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Lu F, Marchler GH, Mullokandov M, Omelchenko MV, Robertson CL, Song JS, Thanki N, Yamashita RA, Zhang D, Zhang N, Zheng C, Bryant SH. 2011. CDD: a conserved domain database for the functional annotation of proteins. Nucleic Acids Res. 39:D225-D229. http://dx.doi.org/10.1093/nar/gkq1189.
27. Warner JB, Lolkema JS. 2003. CcpA-dependent carbon catabolite repression in bacteria. Microbiol. Mol. Biol. Rev. 67:475-490. http://dx.doi.org/10.1128/MMBR.67.4.475-490.2003.
28. Li J, Huang C, Zheng D, Wang Y, Yuan Z. 2012. CcpA-mediated enhancement of sugar and amino acid metabolism in Lysinibacillus sphaericus by NMR-based metabolomics. J. Proteome Res. 11:4654-4661. http://dx.doi.org/10.1021/pr300469v.
29. Leboeuf C, Leblanc L, Auffray Y, Hartke A. 2000. Characterization of the ccpA gene of Enterococcus faecalis: identification of starvation-inducible proteins regulated by ccpA. J. Bacteriol. 182:5799-5806. http://dx.doi.org/10.1128/JB.182.20.5799-5806.2000.
30. Seidl K, Stucki M, Ruegg M, Goerke C, Wolz C, Harris L, Berger-Bachi B, BischoffM. 2006. Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrob. Agents Chemother. 50:1183-1194. http://dx.doi.org/10.1128/AAC.50.4.1183-1194.2006.
31. Abranches J, Nascimento MM, Zeng L, Browngardt CM, Wen ZT, Rivera MF, Burne RA. 2008. CcpA regulates central metabolism and virulence gene expression in Streptococcus mutans. J. Bacteriol. 190:2340-2349. http://dx.doi.org/10.1128/JB.01237-07.
32. Antunes A, Camiade E, Monot M, Courtois E, Barbut F, Sernova NV, Rodionov DA, Martin-Verstraete I, Dupuy B. 2012. Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile. Nucleic Acids Res. 40:10701-10718. http://dx.doi.org/10.1093/nar/gks864.
33. Varga J, Stirewalt VL, Melville SB. 2004. The CcpA protein is necessary for efficient sporulation and enterotoxin gene (cpe) regulation in Clostridium perfringens. J. Bacteriol. 186:5221-5229. http://dx.doi.org/10.1128/JB.186.16.5221-5229.2004.
34. Nuxoll AS, Halouska SM, Sadykov MR, Hanke ML, Bayles KW, Kielian T, Powers R, Fey PD. 2012. CcpA regulates arginine biosynthesis in Staphylococcus aureus through repression of proline catabolism. PLoS Pathog. 8:e1003033. http://dx.doi.org/10.1371/journal.ppat.1003033.
35. Antunes A, Martin-Verstraete I, Dupuy B. 2011. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol. Microbiol. 79:882-899. http://dx.doi.org/10.1111/j.1365-2958.2010.07495.x.
36. Varga JJ, Therit B, Melville SB. 2008. Type IV pili and the CcpA protein are needed for maximal biofilm formation by the Gram-positive anaerobic pathogen Clostridium perfringens. Infect. Immun. 76:4944-4951. http://dx.doi.org/10.1128/IAI.00692-08.
37. Stanley NR, Britton RA, Grossman AD, Lazazzera BA. 2003. Identification of catabolite repression as a physiological regulator of biofilm formation by Bacillus subtilis by use of DNA microarrays. J. Bacteriol. 185: 1951-1957. http://dx.doi.org/10.1128/JB.185.6.1951-1957.2003.
38. Seidl K, Goerke C, Wolz C, Mack D, Berger-Bachi B, BischoffM. 2008. Staphylococcus aureus CcpA affects biofilm formation. Infect. Immun. 76: 2044-2050. http://dx.doi.org/10.1128/IAI.00035-08.
39. Sadykov MR, Hartmann T, Mattes TA, Hiatt M, Jann NJ, Zhu Y, Ledala N, Landmann R, Herrmann M, Rohde H, BischoffM, Somerville GA. 2011. CcpA coordinates central metabolism and biofilm formation in Staphylococcus epidermidis. Microbiology 157:3458-3468. http://dx.doi.org/10.1099/mic.0.051243-0.
40. Shelburne SA, III, Keith D, Horstmann N, Sumby P, Davenport MT, Graviss EA, Brennan RG, Musser JM. 2008. A direct link between carbohydrate utilization and virulence in the major human pathogen groupA Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 105:1698-1703. http://dx.doi.org/10.1073/pnas.0711767105.
41. Iyer R, Baliga NS, Camilli A. 2005. Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae. J. Bacteriol. 187:8340-8349. http://dx.doi.org/10.1128/JB.187.24.8340-8349.2005.
42. Chiang C, Bongiorni C, Perego M. 2011. Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA. J. Bacteriol. 193:52-62. http://dx.doi.org/10.1128/JB.01656-09.
43. Gao P, Pinkston KL, Bourgogne A, Cruz MR, Garsin DA, Murray BE, Harvey BR. 2013. Library screen identifies Enterococcus faecalis CcpA, the catabolite control protein A, as an effector of Ace, a collagen adhesion protein linked to virulence. J. Bacteriol. 195:4761-4768. http://dx.doi.org/10.1128/JB.00706-13.
44. Tang Y, Wu W, Zhang X, Lu Z, Chen J, Fang W. 2012. Catabolite control protein A of Streptococcus suis type 2 contributes to sugar metabolism and virulence. J. Microbiol. 50:994-1002. http://dx.doi.org/10.1007/s12275-012-2035-3.
45. Leenhouts K, Buist G, Bolhuis A, ten Berge A, Kiel J, Mierau I, Dabrowska M, Venema G, Kok J. 1996. A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol. Gen. Genet. 253:217-224. http://dx.doi.org/10.1007/s004380050315.